Table 4.

Percent of Patients Reporting Drug-Related Adverse Events*by Symptom and Treatment Group

PlaceboSumatriptan NS (mg/Dose)
5 mg10 mg20 mg
Total, n(%)23 (18%)45 (35%)51 (38%)47 (40%)
Disturbance of taste2 (2%)24 (19%)40 (30%)31 (26%)
Nausea10 (8%)12 (9%)7 (5%)13 (11%)
Vomiting2 (2%)6 (5%)4 (3%)6 (5%)
Triptan sensation 2 (2%)1 (<1%)3 (2%)5 (4%)
  • * Adverse event ≥3% in the active treatment group.

  • Temperature (warmth), burning/stinging sensations, or paresthesia.